The prospect of integrating exosomal protein, lipid, RNA, and miRNA in cancer diagnosis and prognostic assessment is now being studied, given the current sophistication of analytical techniques. Using a mix of exosomal biomarkers, such as metabolites, RNAs, and proteins that uniquely represent disease...